Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1229.80
-15.95 (-1.28%) DR Reddy's Laboratories informs about press release
Date: 19-03-2024DR Reddy's Laboratories has enclosed a Press Release on ‘Dr. Reddy's Laboratories launches Versavo (bevacizumab) in the UK’.
The above information is a part of company’s filings submitted to BSE.